1. Adaptive licensing: taking the next step in the evolution of drug approval;Eichler;Clin. Pharmacol. Ther.,2012
2. Managed Entry Agreements for Pharmaceuticals: the European Experience. EMiNet;Ferrario,2013
3. European Commission Health and Consumers Directorate-General, Explanatory Note on the Joint Procurement Initiative. Available at: http://ec.europa.eu/health/preparedness_response/docs/jpa_explanatory_en.pdf, May 2014.
4. WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Glossary of pharmaceutical terms, Update 2013, Vienna, 2013.
5. Report on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (COM(2014)0557?C8–0142/2014–2014/0256(COD)). Available at: http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+REPORT+A8-2016-0035+0+DOC+XML+V0//EN&language=en, February 2016.